OPS-Code 8-530.62:
Nuclear medicine therapy: Therapy with unsealed radionuclides: Intravenous therapy with radioactive receptor-targeting drugs: Receptor-mediated radionuclide therapy with chelator-conjugated somatostatin analogs not produced for individual patients
You were treated with a radioactive drug.
Radioactive drugs emit radiation. The intention is for the radiation to damage pathologically altered cells in the body.Radioactive drugs are used for tumors, among other things.The tissue in the body is made up of cells. A tumor disorder involves the cells multiplying more than normal. This results in abnormal or excess tissue forming. A tumor can be benign or malignant.
The cells of the body have typical proteins on their surfaces that differ depending on the type, role and origin of the cell. Various chemical messengers produced by the body can bind to some of these proteins. These proteins are also known as receptors. Many bodily functions are controlled by chemical messengers and the corresponding receptors. Your tumor cells have a very large number of receptors on their surface for a chemical messenger called somatostatin.
You were given a radioactive drug via a blood vessel. The drug spreads through the body via the blood. It detects the somatostatin receptor on the surface of the tumor cells and binds to it. The drug emits radiation at this site.
Additional indicator
If necessary, additional letters are appended to OPS codes to indicate which side of the body is affected.
- L: Left
- R: Right
- B: Both sides
Note
Your doctor will assist you with any health-related questions and explain the OPS code to you in a direct consultation if necessary.
Source
The explanation of the OPS code was provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).